loadpatents
Patent applications and USPTO patent grants for Genov; Daniel.The latest application filed is for "crystalline form of a quinolinone-carboxamide compound".
Patent | Date |
---|---|
Crystalline form of a quinolinone-carboxamide compound Grant 9,402,840 - Fatheree , et al. August 2, 2 | 2016-08-02 |
Crystalline Form Of A Quinolinone-carboxamide Compound App 20160095849 - Fatheree; Paul R. ;   et al. | 2016-04-07 |
Crystalline form of a quinolinone-carboxamide compound Grant 9,126,994 - Fatheree , et al. September 8, 2 | 2015-09-08 |
Quinolinone-carboxamide compounds as 5-HT.sub.4 receptor agonists Grant 8,962,653 - Marquess , et al. February 24, 2 | 2015-02-24 |
Crystalline Form Of A Quinolinone-carboxamide Compound App 20140256769 - Fatheree; Paul R. ;   et al. | 2014-09-11 |
Quinolinone-carboxamide Compounds As 5-ht4 Receptor Agonists App 20140163063 - Marquess; Daniel ;   et al. | 2014-06-12 |
Crystalline form of a quinolinone-carboxamide compound Grant 8,658,671 - Fatheree , et al. February 25, 2 | 2014-02-25 |
Quinolinone-carboxamide compounds as 5-HT.sub.4 receptor agonists Grant 8,309,575 - Marquess , et al. November 13, 2 | 2012-11-13 |
Quinolinone-carboxamide Compounds As 5-ht4 Receptor Agonists App 20120264779 - Marquess; Daniel ;   et al. | 2012-10-18 |
Quinolinone-carboxamide compounds as 5-HT.sub.4 receptor agonists Grant 8,163,920 - Marquess , et al. April 24, 2 | 2012-04-24 |
Quinolinone-carboxamide Compounds As 5-ht4 Receptor Agonists App 20100311979 - Marquess; Daniel ;   et al. | 2010-12-09 |
Quinolinone-carboxamide Compounds As 5-ht4 Receptor Agonists App 20100285519 - Marquess; Daniel ;   et al. | 2010-11-11 |
Crystalline Form Of A Quinolinone-carboxamide Compound App 20100197728 - Fatheree; Paul R. ;   et al. | 2010-08-05 |
Quinolinone-carboxamide compounds as 5-HT.sub.4, receptor agonists Grant 7,763,637 - Marquess , et al. July 27, 2 | 2010-07-27 |
Crystalline form of a quinolinone-carboxamide compound Grant 7,728,004 - Fatheree , et al. June 1, 2 | 2010-06-01 |
Process for preparing intermediates to 5-HT.sub.4 receptor agonist compounds Grant 7,671,198 - Genov , et al. March 2, 2 | 2010-03-02 |
Quinolinone-carboxamide compounds as 5-HT4, receptor agonists App 20080176895 - Marquess; Daniel ;   et al. | 2008-07-24 |
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists Grant 7,375,114 - Marquess , et al. May 20, 2 | 2008-05-20 |
Quinolinone-Carboxamide Compounds as 5-Ht4 Receptor Agonists App 20070281970 - Marquess; Daniel ;   et al. | 2007-12-06 |
Quinolinone-carboxamide compounds as 5-HT, receptor agonists App 20070270457 - Marquess; Daniel ;   et al. | 2007-11-22 |
Process for preparing intermediates to 5-HT4 receptor agonist compounds App 20070191355 - Genov; Daniel ;   et al. | 2007-08-16 |
Crystalline form of a quinolinone-carboxamide compound App 20060229332 - Fatheree; Paul R. ;   et al. | 2006-10-12 |
Crystalline form of an indazole-carboxamide compound App 20060183901 - Fatheree; Paul R. ;   et al. | 2006-08-17 |
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists App 20050228014 - Marquess, Daniel ;   et al. | 2005-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.